Increased levels of adiponectin are also associated with increased insulin sensitivity and general anti-inflammatory reactions for many inflammatory conditions in addition to obesity, such as asthma (Coffey et al., 2015) and inflammatory bowel disease (Yamamoto et al., 2005). Here, ADIPOQ is linked to obesity disorder.